Tandem Diabetes Care Inc at Jefferies Healthcare Conference Transcript
Okay. We're ready to get started here with our next session. I'm really pleased to be joined by the management team from Tandem. And I'm Matt Taylor, the U.S. medical supplies and devices analyst here at Jefferies. I just want to introduce the team. John Sheridan is the President and CEO; and Leigh Vosseller is the CFO. So we're meant to have about a 25-minute Q&A session that I'll drive via a fireside chat, and then maybe we'll have a couple of minutes at the end if the audience has any questions.
Questions & Answers
So I'll give you my first question here from the podium and then joining there in the green room. But I always like to start high level. So maybe stepping back, talking about the insulin pump market. It's been growing nicely in the past few years and really driven by a lot of advances in the technology, not only of the pumps, but of the enabling tech, whether it's CGMs or software. But I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
